EUVIMEDEUVIMED entdecken
Crossref

Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes

Jian-Jun Liu iD, Sylvia Liu, Huili Zheng, Chin-Pin Wang, Subrata Debnath, Janus Lee, Lye Siang Lee, Jianhong Ching, Ming Shen Tham, Keven Ang, Resham L Gurung, Thomas M Coffman und 2 weitere

Diabetes · 2026

DOI: 10.2337/db25-0782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Jian-Jun Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Amino Acids, Branched-Chain, Renal Insufficiency, Chronic, Diabetic Nephropathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Singapore National Medical Research Council Grants, Khoo Teck Puat Hospital STAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preclinical studies suggest that activating branched-chain amino acid (BCAA) catabolism may improve chronic kidney disease (CKD). In this prospective clinical study, we sought to examine the association between urinary BCAA excretion and risk of CKD progression in patients with type 2 diabetes. Baseline urinary BCAAs were measured by mass spectrometry in 1,868 outpatients with type 2 diabetes. The study outcome was a composite of end-stage kidney disease (estimated glomerular filtration rate <15 mL/min/1.73 m2, dialysis, or death resulting from renal causes) or doubling of serum creatinine. During a median of 7.2 years of follow-up, 203 renal events were identified. One SD increment in urinary valine, leucine, and isoleucine concentration was associated with 1.29-fold (95% CI 1.11–1.51), 1.31-fold (1.11–1.55) and 1.29-fold (1.09–1.53) increased risk, respectively, of the composite renal outcome after adjustment for clinical risk factors. Mediation analysis showed that urinary MCP-1 mediated 57%, 47%, and 58% of the effects of valine, leucine, and isoleucine on the renal outcome, respectively. High levels of urinary BCAAs were also independently associated with an increased risk of CKD progression in the Chronic Renal Insufficiency Cohort in the U.S. Our data suggest that dysregulation of BCAA metabolism in the kidneys may be involved in intrarenal inflammation and drive CKD progression. Article Highlights Restoration of branched-chain amino acid (BCAA) catabolism improves kidney pathology in animal models, but clinical data on the relationship between urinary BCAA excretion and kidney outcomes are scarce. Are urinary BCAA levels associated with CKD progression independent of clinical risk factors in patients with type 2 diabetes? High levels of urinary BCAAs predicted an increased risk of renal events independent of cardiorenal risk factors, with urinary MCP-1 mediating over 50% of the association. Activating intrarenal BCAA catabolism may potentially improve kidney function in patients with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Amino Acids, Branched-ChainRenal Insufficiency, ChronicDiabetic NephropathiesHumansDisease ProgressionMaleFemaleMiddle Aged

Substanzen

Amino Acids, Branched-Chain

Autor:innen und Institutionen

  • Clinical Research Unit, Khoo Teck Puat Hospital, Singapore.
  • Department of Population Health Sciences, University of Texas Health, San Antonio, TX.
  • Centre for Precision Medicine, University of Texas Health, San Antonio, TX.
  • Department of Medicine, University of Texas Health, San Antonio, TX.
  • Duke-National University of Singapore Medical School, Singapore.
  • Saw Swee Hock School of Public Heath, National University of Singapore, Singapore.

ORCID-Profile: Jian-Jun Liu, Su Chi Lim

Förderung

  • Singapore National Medical Research Council Grants
  • Khoo Teck Puat Hospital STAR

Zitieren

APA

Liu, J. J., Liu, S., Zheng, H., Wang, C. P., Debnath, S., Lee, J., Lee, L. S., Ching, J., Tham, M. S., Ang, K., Gurung, R. L., Coffman, T. M., Sharma, K., & Lim, S. C. (2026). Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes. Diabetes. https://doi.org/10.2337/db25-0782

Vancouver

Liu JJ, Liu S, Zheng H, Wang CP, Debnath S, Lee J, et al. Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes. Diabetes. 2026. doi:10.2337/db25-0782

BibTeX
@article{Liu2026,
  author = {Liu, Jian-Jun and Liu, Sylvia and Zheng, Huili and Wang, Chin-Pin and Debnath, Subrata and Lee, Janus and Lee, Lye Siang and Ching, Jianhong and Tham, Ming Shen and Ang, Keven and Gurung, Resham L and Coffman, Thomas M and Sharma, Kumar and Lim, Su Chi},
  title = {Urinary Branched-Chain Amino Acid Excretion and Chronic Kidney Disease Progression in Patients With Type 2 Diabetes},
  journal = {Diabetes},
  year = {2026},
  doi = {10.2337/db25-0782}
}
Kostenlos starten →